HUP0104942A2 - Policiklusos tiazolidin-2-ilidén-aminok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk - Google Patents

Policiklusos tiazolidin-2-ilidén-aminok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk

Info

Publication number
HUP0104942A2
HUP0104942A2 HU0104942A HUP0104942A HUP0104942A2 HU P0104942 A2 HUP0104942 A2 HU P0104942A2 HU 0104942 A HU0104942 A HU 0104942A HU P0104942 A HUP0104942 A HU P0104942A HU P0104942 A2 HUP0104942 A2 HU P0104942A2
Authority
HU
Hungary
Prior art keywords
alkyl
carbon atom
phenyl
group
thienyl
Prior art date
Application number
HU0104942A
Other languages
English (en)
Inventor
Karl Geisen
Gerhard Jähne
Hans Jochen Lang
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of HUP0104942A2 publication Critical patent/HUP0104942A2/hu
Publication of HUP0104942A3 publication Critical patent/HUP0104942A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A tal lm ny policiklusos tiazolidin-2-ilidén-aminokra, valamint ezekfiziológiailag elfogadható sóira és fiziológiailag reakcióképes szrmazékaira vonatkozik. A tal lm ny policiklusos tiazolidin-2-ilidén-aminok (I) ltal nos képletében a szubsztituensek jelentése az albbiakban megadott. A tal lm ny kiterjed a fiziológiailag elfogadhatósókra és az azok elő llít s ra szolg ló elj r sra és a vegyületekettartalmazó gyógyszerkészítmények is. A tal lm ny szerinti vegyületekétv gycs"kkentőként alkalmazhatók. Y jelentése vegyértékvonal, -CH2-vagy -CH2-CH2- csoport; X jelentése -CH2, CH(CH3), CH(C2H5), CH(C3H7);R1 jelentése ciano-, karboxil-, COO-(1-6 szénatomos alkil)-,karboxamido-, CONH-(1-6 szénatomos alkil)-, CON(1-6 szénatomosalkil)2, 2-6 szénatomos alkil-, 2-6 szénatomos alkenil-, 2-6szénatomos alkinil-, O-CH2-CF3, O-CH2-CF2-CF3 vagy O-(4-6 szénatomosalkil)-csoport, ahol az alkilcsoportokban egy vagy t"bb vagyvalamennyi hidrogénatomot fluoratom helyettesíthet, vagy egyhidrogénatom hidroxil-, OC(O)CH3, O-CH2-fenil, amin vagy N(COOCH2Ph)2csoporttal lehet helyettesítve, S-(1-6 szénatomos alkil)-, S-(CH2)n-fenil-, SO2-(1-6 szénatomos alkil)-, SO2- (CH2)n-fenil-, SO2-(1-6szénatomos alkil)-, SO2-(CH2)n-fenilcsoport, ahol n 0-6 k"z"tti egészsz m; R1' jelentése hidrogén-, fluor-, klór-, bróm- vagy jódatom, vagymetil-, trifluor-metil-, O-(1-3 szénatomos alkil)-, nitro-, SO2-NH2-,SO2NH(1-6 szénatomos alkil)-, SO2N-(1-6 szénatomos alkil)2- vagy R1,R2 jelentése hidrogénatom, 1-6 szénatomos alkil-, 3-6 szénatomoscikloalkil-, (CH2)n-fenil-, (CH2)n-tienil-, (CH2)n-piridil-, (CH2)n-furil-, C(O)-(CH2)n-fenil-, C(O)-(CH2)n-tienil-, C(O)-(CH2)n-piridil-,C(O)-(CH2)n-furilcsoport, ahol n értéke 0-5 k"z"tti egész sz m lehet,és ahol a fenil-, tienil-, piridil- vagy furilcsoport legfeljebb kettőklór-, fluoratommal, ciano-, trifluor-metil-, 1-3 szénatomos alkil-,hidroxil-, O-(1-6 szénatomos alkil)-csoporttal lehet szubsztitu lva,C(O)-(1-6 szénatomos alkil)-, C(O)-(3-6 szénatomos cikloalkil)-csoport; R3 jelentése hidrogénatom, 1-6 szénatomos alkil-, fluoratom,ciano- vagy azidocsoport, O-(1-6 szénatomos alkil)-, CH2-COO(1-6szénatomos alkil)-, CH2-COO(3-8 szénatomos cikloalkil)-, CH2- COOH,CH2-CONH2, CH2-CONHCH3, CH2-CON(CH3)2, (CH2)n-fenil-, (CH2)n-tienil-,(CH2)n-piridil-, (CH2)n-furilcsoport, ahol n 0-5 k"z"tti egész sz mlehet, és ahol a fenil-, tienil-, piridil- vagy furilcsoportlegfeljebb két klór-, fluoratommal, ciano-, trifluor-metil-, 1-3szénatomos alkil-, hidroxil-, O-(1-6 szénatomos alkil)-csoporttallehet szubsztitu lva, 2-6 szénatomos alkinil-, 2-6 szénatomosalkenil-, C(O)OCH3, C(O)OCH2CH3, C(O)OH, C(O)NH2, C(O)NHCH3,C(O)N(CH3)2 vagy OC(O)CH3 csoport; R4 jelentése 1-6 szénatomos alkil-,3-6 szénatomos cikloalkil-, (CH2)n-fenil=, (CH2)n-tienil-; (CH2)n-piridil-, (CH2)n-furilcsoport, ahol n értéke 0-5 k"z"tti e
HU0104942A 1998-07-17 1999-07-03 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments HUP0104942A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19831878A DE19831878C2 (de) 1998-07-17 1998-07-17 Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/004644 WO2000004006A1 (de) 1998-07-17 1999-07-03 Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
HUP0104942A2 true HUP0104942A2 (hu) 2002-04-29
HUP0104942A3 HUP0104942A3 (en) 2003-12-29

Family

ID=7874197

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104942A HUP0104942A3 (en) 1998-07-17 1999-07-03 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments

Country Status (26)

Country Link
US (1) US6159996A (hu)
EP (1) EP1098891B1 (hu)
JP (1) JP3541808B2 (hu)
KR (1) KR20010083118A (hu)
CN (1) CN1144797C (hu)
AR (1) AR019925A1 (hu)
AT (1) ATE301645T1 (hu)
AU (1) AU767151B2 (hu)
BR (1) BR9912151A (hu)
CA (1) CA2337838A1 (hu)
CL (1) CL2004000219A1 (hu)
DE (2) DE19831878C2 (hu)
DK (1) DK1098891T3 (hu)
ES (1) ES2246089T3 (hu)
HK (1) HK1038560A1 (hu)
HU (1) HUP0104942A3 (hu)
ID (1) ID26985A (hu)
IL (1) IL140767A (hu)
NO (1) NO318790B1 (hu)
NZ (1) NZ509395A (hu)
PL (1) PL345619A1 (hu)
PT (1) PT1098891E (hu)
RU (1) RU2236405C2 (hu)
TR (1) TR200100125T2 (hu)
WO (1) WO2000004006A1 (hu)
ZA (1) ZA200100279B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908537A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908533A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
BR0015322A (pt) * 1999-11-05 2002-07-09 Aventis Pharma Gmbh Derivados de indeno-, nafto- e benzociclohepta-dihidrotiazol, sua preparação e seu emprego como medicamentos anoréticos
DK1261593T3 (da) * 2000-02-26 2003-12-01 Aventis Pharma Gmbh 8,8a-Dihydro-indeno[1,2-d]thiazol-derivater med en sulfonamido- eller sulfonosubstituent i 2-stillingen, en fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
US7977532B2 (en) * 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
EP1767565B1 (en) * 2004-07-09 2015-04-01 Nissan Chemical Industries, Ltd. Process for purification of oligoanilines and oligoanilines
EP2202222A3 (en) * 2005-11-08 2010-09-15 Laboratorios Del Dr. Esteve, S.A. Indene derivatives, their preparation and use as medicaments
EP2276767B1 (en) * 2008-03-31 2014-05-07 Genentech, Inc. Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
CN103443080B (zh) 2011-03-16 2016-10-12 田边三菱制药株式会社 具有trpm8拮抗活性的磺酰胺化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL140767A0 (en) 2002-02-10
ATE301645T1 (de) 2005-08-15
HUP0104942A3 (en) 2003-12-29
NO20010219D0 (no) 2001-01-12
EP1098891B1 (de) 2005-08-10
CA2337838A1 (en) 2000-01-27
ID26985A (id) 2001-02-22
IL140767A (en) 2005-12-18
JP2002520404A (ja) 2002-07-09
EP1098891A1 (de) 2001-05-16
TR200100125T2 (tr) 2001-05-21
AU5030899A (en) 2000-02-07
CN1309653A (zh) 2001-08-22
ZA200100279B (en) 2001-08-07
DK1098891T3 (da) 2005-12-12
ES2246089T3 (es) 2006-02-01
NZ509395A (en) 2003-10-31
WO2000004006A1 (de) 2000-01-27
NO20010219L (no) 2001-03-15
NO318790B1 (no) 2005-05-09
DE19831878C2 (de) 2001-05-17
BR9912151A (pt) 2001-04-10
CN1144797C (zh) 2004-04-07
PL345619A1 (en) 2002-01-02
CL2004000219A1 (es) 2005-04-22
DE19831878A1 (de) 2000-01-27
JP3541808B2 (ja) 2004-07-14
KR20010083118A (ko) 2001-08-31
RU2236405C2 (ru) 2004-09-20
AR019925A1 (es) 2002-03-27
DE59912402D1 (de) 2005-09-15
PT1098891E (pt) 2005-11-30
HK1038560A1 (en) 2002-03-22
US6159996A (en) 2000-12-12
AU767151B2 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
HUP0104942A2 (hu) Policiklusos tiazolidin-2-ilidén-aminok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk
MY102087A (en) Phenethanolamine derivatives.
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
HUP0500497A2 (hu) Fenoxi-piperidin-származékok, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és eljárás előállításukra
MY104376A (en) N-imidazolyl deravatives of bicyclic compounds and process for their preparation.
IE810485L (en) Imidazo compounds
YU29602A (sh) Derivati indeno-, nafto- i benzociklohepta-dihidrotiazola, njihova proizvodnja i njihova primena kao anorektičnih lekova
EP0233793A3 (en) Decahydroquinoline derivatives, process for their preparation, intermediates for their preparation, their use as medicaments and compositions containing them
ATE285410T1 (de) Naphthyridinderivate oder salze davon
DE3362342D1 (en) 1,4-acyloxynaphthalene derivatives, topical compositions containing them, methods for their preparation, and intermediates therefor
ES486824A1 (es) Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas
GB1421970A (en) 8-azapurin-6-one derivatives
ES8802040A1 (es) Un procedimiento para la preparacion de fenialquil-2,3-dihidrobenzofuranos y los correspondientes dihidrobenzopiranos
SE7608152L (sv) Ny metod for framstellning av orto-aminobutyrofenonderivat och salter derav
NZ236032A (en) Napthacenedione derivatives, their preparation and pharmaceutical compositions
ES8404312A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
ES8405406A1 (es) Procedimiento para la preparacion de nuevas 4-fenil-4,5,6,7-tetrahidro-tieno(2,3-c)piridinas sustituidas con radicales basicos
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
IE892294L (en) Cycloalkylthiazole derivatives
DE3460467D1 (en) Hydroquinone derivatives and production thereof
EP0134112A3 (en) Pharmaceutical composition for prophylaxis or treatment of ketosis in livestock
GB1493416A (en) Spasmolytics
ES8401957A1 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
MY107827A (en) Isoquinolline compounds, compositions and use
IE820160L (en) Heterocyclic benzamide derivatives

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees